FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2201215913> ?p ?o ?g. }

• W2201215913 endingPage "2390" @default.
• W2201215913 startingPage "2379" @default.
• W2201215913 abstract "// Yuji Goto 1,2 , Ichiro Yajima 1,3 , Mayuko Kumasaka 1,3 , Nobutaka Ohgami 1,3 , Asami Tanaka 1 , Toyonori Tsuzuki 4 , Yuji Inoue 5 , Satoshi Fukushima 5 , Hironobu Ihn 5 , Mikiko Kyoya 6 , Hiroyuki Ohashi 6 , Tamihiro Kawakami 6 , Dorothy C. Bennett 7 and Masashi Kato 1,3 1 Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Matsumoto-cho, Kasugai-shi, Aichi, Japan 2 Department of Biology, Faculty of Science, Toho University, Miyama, Funabashi, Japan 3 Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan 4 Department of Pathology, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan 5 Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan 6 Department of Dermatology, St. Marianna University School of Medicine, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan 7 Molecular Cell Sciences Research Centre, St George’s, University of London, London, UK Correspondence to: Masashi Kato, email: // Keywords : melanoma, transcription factor LSF, TFCP2, CDKN1A, cell cycle Received : May 28, 2015 Accepted : October 09, 2015 Published : October 25, 2015 Abstract Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent growth of melanoma cells was suppressed by LSF overexpression through an increased percentage of G1 phase cells and an increased p21 CIP1 expression level in vitro and in vivo . Anchorage-dependent growth in LSF-overexpressed melanoma cells was promoted by depletion of LSF in the LSF-overexpressed cells. Integrated results of our EMSA and chromatin immunoprecipitation assays showed binding of LSF within a 150-bp upstream region of the transcription start site of p21 CIP1 in melanoma cells. Taken together, our results suggest potential roles of LSF as a growth regulator through control of the transcription of p21 CIP1 in melanocytes and melanoma cells as well as a biomarker for nevus." @default.
• W2201215913 created "2016-06-24" @default.
• W2201215913 creator A5004693750 @default.
• W2201215913 creator A5010122783 @default.
• W2201215913 creator A5015546959 @default.
• W2201215913 creator A5022600763 @default.
• W2201215913 creator A5022744355 @default.
• W2201215913 creator A5027460005 @default.
• W2201215913 creator A5033451411 @default.
• W2201215913 creator A5034433475 @default.
• W2201215913 creator A5048991469 @default.
• W2201215913 creator A5057381914 @default.
• W2201215913 creator A5064881910 @default.
• W2201215913 creator A5072269058 @default.
• W2201215913 creator A5087317062 @default.
• W2201215913 creator A5089988781 @default.
• W2201215913 date "2015-10-25" @default.
• W2201215913 modified "2023-09-24" @default.
• W2201215913 title "Transcription factor LSF (TFCP2) inhibits melanoma growth" @default.
• W2201215913 cites W1542514992 @default.
• W2201215913 cites W1607548879 @default.
• W2201215913 cites W1790252519 @default.
• W2201215913 cites W1819895792 @default.
• W2201215913 cites W1966065286 @default.
• W2201215913 cites W1978252870 @default.
• W2201215913 cites W1989608005 @default.
• W2201215913 cites W2003447227 @default.
• W2201215913 cites W2005397075 @default.
• W2201215913 cites W2005580242 @default.
• W2201215913 cites W2018433232 @default.
• W2201215913 cites W2033369388 @default.
• W2201215913 cites W2033898588 @default.
• W2201215913 cites W2047054611 @default.
• W2201215913 cites W2058680810 @default.
• W2201215913 cites W2100382690 @default.
• W2201215913 cites W2102763456 @default.
• W2201215913 cites W2121022570 @default.
• W2201215913 cites W2162059614 @default.
• W2201215913 cites W2162545255 @default.
• W2201215913 cites W2163188200 @default.
• W2201215913 cites W2315112762 @default.
• W2201215913 cites W2399427126 @default.
• W2201215913 cites W58329476 @default.
• W2201215913 doi "https://doi.org/10.18632/oncotarget.6230" @default.
• W2201215913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4823042" @default.
• W2201215913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26506241" @default.
• W2201215913 hasPublicationYear "2015" @default.
• W2201215913 type Work @default.
• W2201215913 sameAs 2201215913 @default.
• W2201215913 citedByCount "19" @default.
• W2201215913 countsByYear W22012159132017 @default.
• W2201215913 countsByYear W22012159132018 @default.
• W2201215913 countsByYear W22012159132019 @default.
• W2201215913 countsByYear W22012159132020 @default.
• W2201215913 countsByYear W22012159132021 @default.
• W2201215913 countsByYear W22012159132022 @default.
• W2201215913 countsByYear W22012159132023 @default.
• W2201215913 crossrefType "journal-article" @default.
• W2201215913 hasAuthorship W2201215913A5004693750 @default.
• W2201215913 hasAuthorship W2201215913A5010122783 @default.
• W2201215913 hasAuthorship W2201215913A5015546959 @default.
• W2201215913 hasAuthorship W2201215913A5022600763 @default.
• W2201215913 hasAuthorship W2201215913A5022744355 @default.
• W2201215913 hasAuthorship W2201215913A5027460005 @default.
• W2201215913 hasAuthorship W2201215913A5033451411 @default.
• W2201215913 hasAuthorship W2201215913A5034433475 @default.
• W2201215913 hasAuthorship W2201215913A5048991469 @default.
• W2201215913 hasAuthorship W2201215913A5057381914 @default.
• W2201215913 hasAuthorship W2201215913A5064881910 @default.
• W2201215913 hasAuthorship W2201215913A5072269058 @default.
• W2201215913 hasAuthorship W2201215913A5087317062 @default.
• W2201215913 hasAuthorship W2201215913A5089988781 @default.
• W2201215913 hasBestOaLocation W22012159131 @default.
• W2201215913 hasConcept C126322002 @default.
• W2201215913 hasConcept C143998085 @default.
• W2201215913 hasConcept C16005928 @default.
• W2201215913 hasConcept C2777658100 @default.
• W2201215913 hasConcept C502942594 @default.
• W2201215913 hasConcept C71924100 @default.
• W2201215913 hasConceptScore W2201215913C126322002 @default.
• W2201215913 hasConceptScore W2201215913C143998085 @default.
• W2201215913 hasConceptScore W2201215913C16005928 @default.
• W2201215913 hasConceptScore W2201215913C2777658100 @default.
• W2201215913 hasConceptScore W2201215913C502942594 @default.
• W2201215913 hasConceptScore W2201215913C71924100 @default.
• W2201215913 hasIssue "3" @default.
• W2201215913 hasLocation W22012159131 @default.
• W2201215913 hasLocation W22012159132 @default.
• W2201215913 hasLocation W22012159133 @default.
• W2201215913 hasLocation W22012159134 @default.
• W2201215913 hasLocation W22012159135 @default.
• W2201215913 hasOpenAccess W2201215913 @default.
• W2201215913 hasPrimaryLocation W22012159131 @default.
• W2201215913 hasRelatedWork W1969276543 @default.
• W2201215913 hasRelatedWork W1995463208 @default.
• W2201215913 hasRelatedWork W2021968456 @default.
• W2201215913 hasRelatedWork W2068861579 @default.
• W2201215913 hasRelatedWork W2412245334 @default.

• next